Rallarvagen, Sweden

Marianne Pedersen

This inventor holds 1 USPTO granted patent. Top assignee: T&m Biopolymer Aktiebolag. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marianne Pedersen. Retrieved from https://idiyas.com/inventor/marianne-pedersen-6asuhx2j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Marianne Pedersen

Introduction

Marianne Pedersen is a notable inventor based in Rallarvagen, Sweden. She has made significant contributions to the field of biopolymers, particularly through her innovative work in enzymatic processes.

Latest Patents

Marianne holds a patent for "Glucan lyase producing 1,5-anhydrofructose." This invention showcases her expertise in biochemistry and its applications in creating valuable compounds.

Career Highlights

Marianne is currently employed at T&M Biopolymer Aktiebolag, where she continues to push the boundaries of biopolymer research. Her work has been instrumental in advancing the understanding of enzymatic reactions and their potential applications in various industries.

Collaborations

Throughout her career, Marianne has collaborated with esteemed colleagues such as Lennart Kenne and Shukun Yu. These partnerships have fostered a rich environment for innovation and discovery.

Conclusion

Marianne Pedersen's contributions to the field of biopolymers and her innovative patent highlight her role as a leading inventor in her domain. Her work continues to inspire advancements in biochemistry and its applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…